Senaste uppdateringen :
27/11/2024
forskargrupper - University of Southern california, School of Pharmacy   pdf  
Förenta Staterna
universitet
University of Southern california, School of Pharmacy
Los Angeles
Email
Hänvisningar   Hänvisningar   (20)  
1
Extended stability of ascorbic acid in 5% dextrose injection and 0.9% sodium chloride injection.
Chin A, Liu S, Ting-Chan J, Gill MA. ()
Am J Health-Syst Pharm - 2005 - ; 62: 1073-1074.
2
Stability and antibacterial activity of cefepime during continuous infusion.
Sprauten PF, Beringer PM, Louie ST, Synold TW, Gill MA. ( beringer@usc.edu)
Antimicrob Agents Chemother - 2003 - ; 47: 1991-1994.
3
Stability of irinotecan hydrochloride in aqueous solutions.
Li WY, Koda RT. (mppugari@hsc.usc.edu)
Am J Health-Syst Pharm - 2002 - ; 59: 539-544.
4
Activity of dalteparin sodium in polypropylene syringes.
Louie S, Chin A, Gill MA. (mgill@hsc.usc.edu)
Am J Health-Syst Pharm - 2000 - ; 57: 760-762.
5
Stability of sumatriptan succinate in polypropylene syringes.
Nii LJ, Chin A, Cao TM, Gill MA. ()
Am J Health-Syst Pharm - 1999 - ; 56: 983-985.
9
Stability of granisetron hydrochloride with dexamethasone sodium phosphate for 14 days.
Chin A, Moon YSK, Chung KC, Gill MA. ()
Am J Health-Syst Pharm - 1996 - ; 53: 1174-1176.
10
Compatibility of ondansetron hydrochloride and piperacillin sodium-tazobactam sodium during simulated Y-site administration.
Chung KC, Moon YSK, Chin A, Ulrich WU, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1554-1556.
11
Stability of granisetron hydrochloride in a disposable elastomeric infusion device.
Chung KC, Chin A, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 1541-1543.
12
Stability of piperacillin sodium-tazobactam sodium in polypropylene syringes and polyvinyl chloride minibags.
Moon YSK, Chung KC, Chin A, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 999-1001.
13
Stability of piperacillin sodium-tazobactam sodium in peritoneal dialysis solutions
Park TW, Le-Bui LP, Chung KC, Rho JP, Gill MA. ()
Am J Health-Syst Pharm - 1995 - ; 52: 2022 - 2024.
14
Stability of ranitidine hydrochloride with ondansetron hydrochloride or fluconazole during simulated Y-site administration.
Pompilio FM, Fox JL, Inagaki K, Burm JP, Jhee S, Gill MA. ()
Am J Hosp Pharm - 1994 - ; 51: 391-394.
15
Stability of paclitaxel and fluconazole during simulated Y-site administration.
Burm JP, Choi JS, Jhee SS, Chin A, Ulrich RW, Gill MA. ()
Am J Hosp Pharm - 1994 - ; 51: 2704-2706.
16
Stability of paclitaxel with ondansetron or ranitidine hydrochloride during simulated Y site administration.
Burm JP, Jhee SS, Chin A, Moon YSK. ()
Am J Hosp Pharm - 1994 - ; 51: 1201-1204.
17
Stability of piperacillin sodium-tazobactam sodium and ranitidine hydrochloride in 0.9% sodium chloride injection during simulated Y-site administration.
Choi JS, Burm JP, Jhee SS, Chin A, Ulrich RW, Gill MA. ()
Am J Hosp Pharm - 1994 - ; 51: 2273-2276.
18
Stability of ondansetron hydrochloride stored in a disposable, elastomeric infusion device at 4°C.
Jhee SS, Jeong EW, Chin A, Inagaki K, Fox JL, Gill MA. ()
Am J Hosp Pharm - 1993 - ; 50: 1918-1920.
20
Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration.
Inagaki K, Gill MA, Okamoto MP, Takagi J. ()
J Parenter Sci Technol - 1993 - ; 47: 35-39.

 Förteckning över substanser   molekyler Studerade   (21)  

  Mentions Légales